PIK3CD and acute lymphoblastic leukemia: Further, Silveira et al. [21] combined an alternative pan-PI3K inhibitor (AS605240) with the glucocorticoid Prednisolone and detected enhanced anti-leukemic effects in T-ALL cells compared to the respective mono agents in vitro.